Madison, WI – April 9, 2024 – Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic research agreement with Astellas Pharma, a global pharmaceutical... read more →
MADISON, Wis. – Apr 2, 2024 – Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Development and... read more →
- Expanded collaboration to include an additional 20 targets for multi-specific antibody, antibody-drug conjugate, and other biologic candidate discovery and development - ALAMEDA, Calif., & MADISON, Wis. – August 16,... read more →